Azitra, Inc.
AZTRDrugs in Pipeline
1
Phase 3 Programs
0
Upcoming Catalysts
1
Next Catalyst
Jan 2027
Market Overview
Stock performance and key metrics
1 upcoming, 0 past
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
ATR04-484 | Phase 2 | EGFR Inhibitor-associated Rash | - | - |
Full breakdown — the signals behind the verdict
Frequently asked questions
What is in Azitra, Inc.'s drug pipeline?→
CatalystAlert tracks 1 drug candidate in Azitra, Inc.'s (AZTR) pipeline across Phase 2. Its lead program is ATR04-484 (Phase 2). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Azitra, Inc.'s next FDA catalyst?→
Azitra, Inc.'s (AZTR) next tracked catalyst is a Phase 2 expected January 15, 2027. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.
How do I track AZTR biotech catalysts?→
Add AZTR to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Azitra, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.